To confirm the degree of lung injury in this early-phase model of ALI [26], we measured mRNA expression of interleukin-1-beta (IL-1β), which is a net mediator of inflammatory activity [27] in addition to being secreted early in the process [10,28] and responsive to changes in ventilatory strategies [29]. The gene discussed is IL1B; the disease is acute respiratory distress syndrome.